Masahiro et al. reported a strong association between VHL alterations in sporadic ccRCC and better cancer-free survival and cancer-specific survival in non-metastatic disease treated with radical nephrectomy (RN), particularly in stage III patients [69]. The gene discussed is VHL; the disease is cancer.